Skip to main content
OpenTrials

Clinical trial condition

Meningitis

Explore clinical trials studying Meningitis. Study availability and eligibility vary by location and protocol.

118 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Meningitis trial results

Completed

Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

NCT02752906

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Number 016 Birmingham, Alabama, United States
  • Investigational Site Number 032 Dothan, Alabama, United States
  • Investigational Site Number 026 Mesa, Arizona, United States
  • Investigational Site Number 022 Jonesboro, Arkansas, United States
View all 30 locations
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

NCT02842866

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Chandler, Arizona, United States
  • Anaheim, California, United States
  • San Diego, California, United States
  • Waterbury, Connecticut, United States
View all 36 locations
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers

NCT02955797

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site 309 Espoo, Finland
  • Investigational Site 301 Helsinki, Finland
  • Investigational Site 306 Helsinki, Finland
  • Investigational Site 302 Jarvenpaa, Finland
View all 33 locations
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT03205358

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Number 005 Espoo, Finland
  • Investigational Site Number 006 Helsinki, Finland
  • Investigational Site Number 002 Helsinki, Finland
  • Investigational Site Number 007 Jarvenpaa, Finland
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

NCT02199691

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Birmingham, Alabama, United States
  • Huntsville, Alabama, United States
  • Downey, California, United States
  • San Diego, California, United States
View all 36 locations
View Trial Details
Completed

Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years

NCT03077438

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Dothan, Alabama, United States
  • Investigational Site Tucson, Arizona, United States
  • Investigational Site Jonesboro, Arkansas, United States
View all 36 locations
View Trial Details
Completed

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth

NCT00459316

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations
  • Usc La Nichd Crs Alhambra, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
  • Children's Hospital of Los Angeles NICHD CRS Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
View all 37 locations
View Trial Details

Related conditions